DVLP Issues LOI to Acquire Emerging Cannabis Dispensary Point-of-Sale Ad Tech Play

Austin, Texas, UNITED STATES

AUSTIN, Texas, Nov. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis and CBD marketplace, is very excited to announce its Letter of Intent to acquire a rapidly growing Cannabis dispensary PoS advertising player, in a restricted stock and cash deal valued on a pre-acquisition basis at over $4 million.

DVLP CEO, Stavros Triant, comments, “We believe the lion’s share of investment returns for the farmers has already been made. The next phase will be a new strategic landscape in the cannabis sector defined by falling cannabis prices and massive growth in consumer and B2B services as mainstream public adoption accelerates in North America.”

Digital media advertising is an emerging technology focused on enhancing the effectiveness of brand visibility at the point of sale in dispensaries, while advertising selected cannabis related products with an in-store display that pulsates a link to an active ad network. Their network has over 100 locations already, and continues to grow rapidly. With the total number of dispensaries continuing to grow in North America every month for the past three years, and the possibility of acceleration with any new move toward more comprehensive legalization in the US, management believes the available market size has the potential to expand dramatically.

In addition, this move follows the Company’s recent acquisition of Where’s Weed, an online and mobile cannabis services hub. Management believes these two brands will have tremendous synergies under the same umbrella – one controlling a share of the market directing consumers to dispensaries, and the other controlling a share of the market directing consumers to specific purchase decisions once there, and further directing attention back out to a linked online platform.

“We strongly believe Where’s Weed will ignite each additional acquisition and have exceptional synergy, putting DVLP in an industry-dominant position in cannabis services,” continued Mr. Triant. “The Cannabis market is set to grow by leaps and bounds, with experts predicting a move to $55-75 billion in total market size in coming years. We are working now to get ahead of the curve as that growth begins to shift away from farming capacity and toward connecting new consumers with specific cannabis experiences.”

According to Mordor Intelligence, the global cannabis market is set to grow at over 37% CAGR to reach as much as $65 billion by 2023. While this is mostly attributable to increasing legalization, the massive flow of investment capital into growing capacity over the past two years may bring down cannabis pricing through increased supply, suggesting that growth in cannabis services, such as dispensary location and in-image advertising at point-of-sale, will begin to harness an increasing share of this total growth pie.

About Golden Developing Solutions, Inc.
Golden Developing Solutions (DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. Through the website of its joint venture partner, Pura Vida Vitamins (www.PuraVidaVitamins.com), as well as through wholesale and distribution channels, the company offers a broad range of high-quality, price-competitive products, including traditional vitamins, supplements, and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle.

Golden Developing Solutions is a development-stage company providing business services and/or products supporting the cannabis industry, in which company intends to make acquisitions in the near future. Currently, 29 states and the District of Columbia have passed laws permitting their citizens to use cannabis for medical and/or recreational purposes. Cannabis has shown encouraging signs as a treatment for various medical conditions and has become increasingly more acceptable to the public and society.

Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Investors are encouraged to review the Company’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced herein are not incorporated into this press release.

Media Contact:

Stavros Triant